Helantera Ilkka, Koskinen Petri, Tornroth Tom, Loginov Raisa, Gronhagen-Riska Carola, Lautenschlager Irmeli
Department of Virology, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland.
Transplantation. 2003 Jun 15;75(11):1858-64. doi: 10.1097/01.TP.0000064709.20841.E1.
The role of cytomegalovirus (CMV) in chronic kidney allograft rejection remains controversial. The purpose of this study was to examine the impact of CMV infection on histopathologic changes in 6-month protocol biopsy specimens of kidney allografts.
Altogether, 52 renal allograft recipients were studied. CMV infection was diagnosed by CMV antigenemia test, viral cultures from blood and urine, or both. CMV was demonstrated in the biopsy specimens by antigen detection and hybridization in situ. Acute rejections were diagnosed by biopsy histology, and biopsy specimens were graded according to the Banff '97 classification.
CMV infection was diagnosed in 41 patients. The 11 patients in whom CMV infection was not detected were used as controls. Acute rejection was diagnosed in 22 of 41 CMV patients and in 6 of 11 control patients. CMV was demonstrated in the biopsy specimens of 19 of 41 CMV patients. CMV was not associated with increased glomerular, tubular, or interstitial changes. However, the arteriosclerotic changes in small arterioles were significantly increased in the subgroup of patients where CMV was demonstrated in the graft as compared with controls (P<0.01). Analysis of the impact of acute rejection on arteriolar thickening showed that only a positive history of both acute rejection and CMV found in the graft was associated with significantly increased vascular changes compared with CMV-free recipients (P<0.05).
Neither CMV nor acute rejection alone was associated with increased vascular or other histopathologic changes in 6-month protocol biopsy specimens of kidney allografts, but a previous history of both acute rejection and the presence of CMV in the graft was associated with increased vascular changes.
巨细胞病毒(CMV)在慢性肾移植排斥反应中的作用仍存在争议。本研究的目的是探讨CMV感染对肾移植6个月方案活检标本组织病理学变化的影响。
共研究了52例肾移植受者。通过CMV抗原血症检测、血液和尿液病毒培养或两者结合来诊断CMV感染。通过抗原检测和原位杂交在活检标本中检测到CMV。通过活检组织学诊断急性排斥反应,并根据Banff '97分类对活检标本进行分级。
41例患者被诊断为CMV感染。11例未检测到CMV感染的患者作为对照。41例CMV感染患者中有22例被诊断为急性排斥反应,11例对照患者中有6例被诊断为急性排斥反应。41例CMV感染患者中有19例的活检标本中检测到CMV。CMV与肾小球、肾小管或间质变化增加无关。然而,与对照组相比,移植肾中检测到CMV的患者亚组中小动脉的动脉硬化变化显著增加(P<0.01)。急性排斥反应对小动脉增厚影响的分析表明,与无CMV感染的受者相比,移植肾中同时存在急性排斥反应和CMV的阳性病史与血管变化显著增加相关(P<0.05)。
在肾移植6个月方案活检标本中,单独的CMV或急性排斥反应均与血管或其他组织病理学变化增加无关,但既往急性排斥反应病史和移植肾中存在CMV与血管变化增加相关。